PMID- 17034506 OWN - NLM STAT- MEDLINE DCOM- 20070201 LR - 20061127 IS - 1464-4096 (Print) IS - 1464-4096 (Linking) VI - 98 IP - 6 DP - 2006 Dec TI - Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients. PG - 1204-9 AB - OBJECTIVE: To assess the association between surgical volume (SV) and the rate of positive surgical margins (PSM) after radical prostatectomy (RP) in a large single-institution European cohort of patients. PATIENTS AND METHODS: In all, 2402 men had a RP by a group of 11 surgeons, all of whom were trained by the surgeon with the highest SV; all surgeons used the same surgical technique. Variables assessed before RP were prostate-specific antigen (PSA) level, clinical stage and biopsy Gleason sum; variables assessed after RP were PSA level, extracapsular extension, seminal vesicle invasion, lymph node invasion and pathological Gleason sum. These were used to predict the rate of PSM in models before or after RP. Multivariate models were complemented with SV to test its independent and multivariate statistical significance and to quantify its impact on the model's overall (and 200 bootstrap-corrected) predictive accuracy. RESULTS: The mean (range) SV was 201 (1-1293) RPs; the mean (median, range) rate of PSM was 20.2 (21.4, 0-32.9)%. In multivariate models, SV was a highly statistically significant independent predictor of PSM (P < 0.001) and increased the predictive accuracy in multivariate models both before (2.0%) and after RP (1.5%, both P < 0.001). However, when the surgeon with the highest SV, who contributed to 1293 cases, was removed from the analyses, the multivariate independent prediction and the gains in predictive accuracy related to adding SV, disappeared in the models both before (P = 0.9, accuracy gain 0.1%) and after (P = 0.4, accuracy gain - 0.3%) RP. CONCLUSIONS: These results indicate that patients treated by surgeons with a very high volume can expect to have a significantly lower rate of PSM, after accounting for clinical and pathological case-mix differences. However, SV is not a predictor of PSM when analyses are restricted to intermediate- and low-volume surgeons. FAU - Chun, Felix K-H AU - Chun FK AD - Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada. FAU - Briganti, Alberto AU - Briganti A FAU - Antebi, Elie AU - Antebi E FAU - Graefen, Markus AU - Graefen M FAU - Currlin, Eike AU - Currlin E FAU - Steuber, Thomas AU - Steuber T FAU - Schlomm, Thorsten AU - Schlomm T FAU - Walz, Jochen AU - Walz J FAU - Haese, Alexander AU - Haese A FAU - Friedrich, Martin G AU - Friedrich MG FAU - Ahyai, Sascha A AU - Ahyai SA FAU - Eichelberg, Christian AU - Eichelberg C FAU - Salomon, Georg AU - Salomon G FAU - Gallina, Andrea AU - Gallina A FAU - Erbersdobler, Andreas AU - Erbersdobler A FAU - Perrotte, Paul AU - Perrotte P FAU - Heinzer, Hans AU - Heinzer H FAU - Huland, Hartwig AU - Huland H FAU - Karakiewicz, Pierre I AU - Karakiewicz PI LA - eng PT - Journal Article DEP - 20061011 PL - England TA - BJU Int JT - BJU international JID - 100886721 RN - EC 3.4.21.77 (Prostate-Specific Antigen) SB - IM MH - Clinical Competence/*standards MH - Cohort Studies MH - Europe MH - Humans MH - Lymphatic Metastasis MH - Male MH - Multivariate Analysis MH - Neoplasm, Residual MH - Prognosis MH - Prospective Studies MH - Prostate-Specific Antigen/blood MH - Prostatectomy/standards/*statistics & numerical data MH - Prostatic Neoplasms/pathology/*surgery MH - Treatment Outcome EDAT- 2006/10/13 09:00 MHDA- 2007/02/03 09:00 CRDT- 2006/10/13 09:00 PHST- 2006/10/13 09:00 [pubmed] PHST- 2007/02/03 09:00 [medline] PHST- 2006/10/13 09:00 [entrez] AID - BJU6442 [pii] AID - 10.1111/j.1464-410X.2006.06442.x [doi] PST - ppublish SO - BJU Int. 2006 Dec;98(6):1204-9. doi: 10.1111/j.1464-410X.2006.06442.x. Epub 2006 Oct 11.